Skip to main content
Top

11-05-2024 | Central Venous Catheter | Editorial Commentary

Thromboembolism in Children: Unveiling Risk-Factors

Authors: Pritam Singha Roy, Deepak Bansal

Published in: Indian Journal of Pediatrics

Login to get access

Excerpt

Though infrequent, thromboembolism (TE) in pediatric patients is on the rise, attributed mainly to the increased utilization of central venous catheters (CVCs) [1]. The fraternity of neonatology, cardiology, and hematology-oncology encounter this daunting problem more frequently. Understanding the risk factors of TE in children is pivotal for identifying at-risk patients and optimizing thromboprophylaxis. The retrospective analysis of the risk-factors, clinical profile, and outcome for TE in children by Öncül et al. is a worthy compilation. The study, conducted at the Department of Pediatric Hematology and Oncology in Malatya, Turkey, examined 84 pediatric TE cases over 11 y [2]. …
Literature
3.
go back to reference Jaffray J, Mahajerin A, Young G, et al. A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children’s Hospital-Acquired Thrombosis (CHAT) project. Thromb Res. 2018;161:67–72.CrossRefPubMed Jaffray J, Mahajerin A, Young G, et al. A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children’s Hospital-Acquired Thrombosis (CHAT) project. Thromb Res. 2018;161:67–72.CrossRefPubMed
4.
go back to reference Goldenberg NA, Abshire T, Blatchford PJ, et al; Kids-DOTT Trial Investigators. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015;13:1597–605.CrossRefPubMedPubMedCentral Goldenberg NA, Abshire T, Blatchford PJ, et al; Kids-DOTT Trial Investigators. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015;13:1597–605.CrossRefPubMedPubMedCentral
5.
go back to reference Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematol Am Soc Hematol Educ Program. 2016;2016:1–9.CrossRef Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematol Am Soc Hematol Educ Program. 2016;2016:1–9.CrossRef
6.
go back to reference Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res. 2014;49:85–94.CrossRefPubMedPubMedCentral Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res. 2014;49:85–94.CrossRefPubMedPubMedCentral
7.
go back to reference Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2:3292–316.CrossRefPubMedPubMedCentral Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2:3292–316.CrossRefPubMedPubMedCentral
Metadata
Title
Thromboembolism in Children: Unveiling Risk-Factors
Authors
Pritam Singha Roy
Deepak Bansal
Publication date
11-05-2024
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-024-05155-5